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In this case report, we describe the extremely rare case of a collision tumor comprising cancers of the bile duct and
the pancreas. A 70-year-old man was referred to our hospital with a diagnosis of obstructive jaundice. He was
diagnosed with pancreatic head cancer, and we performed a pancreaticoduodenectomy with lymph node
dissection. At laparotomy, there were two palpable masses in the vicinity of the confluence of the cystic duct and
the head of the pancreas. The resected specimen demonstrated tumors at the confluence of the cystic duct and in
the pancreatic head. Histopathological examination demonstrated a moderately differentiated tubular adenocarcinoma
in the pancreatic head and a well-differentiated tubular adenocarcinoma at the confluence of the cystic duct.
Immunostaining was negative for p53 and MUC6 in the pancreatic head tumor; however, immunostaining was positive
for both in the tumor located at the confluence of the cystic duct. The two tumors were histologically different and
were diagnosed as collision cancer caused by the collision of the bile duct and pancreatic cancers.
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Collision cancers are malignancies in the same organ or
anatomical site that comprises at least two different
tumor components, with no mixed or transitional area
between two components. Dual cancer involving a com-
bination of pancreatic and bile duct cancers is rare, and
to our knowledge, few cases of a collision cancer com-
posed of these two specific cancers have been previously
reported [1]. We encountered a patient with a very rare




Patient was a 70-year-old male.
Chief complaint
Chief complaint was right upper abdominal pain.* Correspondence: deehii@is.icc.u-tokai.ac.jp
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Past medical history was unremarkable.
Family medical history
Family medical history was unremarkable.
History of present illness
The patient presented to his physician with a chief com-
plaint of right upper abdominal pain in November 2009.
Blood testing demonstrated obstructive jaundice, and
the patient was admitted to our hospital for further
evaluation.
Relevant physical exam
The palpebral conjunctivae were mildly yellow, but no
pallor was noted. The abdomen was flat and soft without
tenderness, and no mass was palpated.
Blood test findings on admission were as follows
(Table 1): aspartate aminotransferase (AST), 179 IU/L; ala-
nine transaminase (ALT), 244 IU/L; alkaline phosphatase
(ALP), 2,097 IU/L; and γ-glutamyltransferase (γ-GTP),
1,246 IU/L. Thus, serum levels of hepatobiliary enzymes
were elevated. Serum level of T-Bil was 2.7 mg/dL and
that of D-Bil was 1.5 mg/dL, demonstrating mild jaundice.Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Laboratory data on admission
Value
WBC 8.4 × 103/μL
RBC 4.56 × 106/μL
Hb 14.0 g/dL
Ht 41.5%



















Figure 1 The tumor boundary within the pancreatic head is unclear
in the non-uniform contrast equilibrium phase-arterial phase.
Izumi et al. Surgical Case Reports  (2015) 1:40 Page 2 of 6Moreover, tumor marker elevation was observed: serum
level of CEA was 13.0 ng/mL and that of CA19-9 was
515.3 U/mL.Abdominal ultrasonography
An approximately 3-cm, low-echoic mass with unclear
boundaries and heterogeneous content was detected in
the pancreatic head. There was a 17.8-mm dilation of
the common bile duct and a 2.9-mm dilation of the cau-
dal pancreatic duct due to the mass.Abdominal computed tomography
There was no clearly visible mass. A mild enhancement of
the intrapancreatic common bile duct wall in both the ar-
terial and the equilibrium phases was detected (Figure 1).
The intrahepatic bile ducts were dilated bilaterally, and
there was mild dilation of the pancreatic duct.Figure 2 Cholangiographic examination shows severe stenosis of
the lower bile duct.Magnetic resonance cholangiopancreatography
The intrapancreatic bile duct tapered off sharply, and
there was marked dilation of the duct proximal to this
obstruction.Endoscopic retrograde cholangiopancreatography
Stenosis of the lower bile duct extending over approxi-
mately 2 cm was noted (Figure 2). An endoscopic retro-
grade biliary drainage tube was inserted. The pancreatic
duct could not be cannulated. Bile cytology was class V.
Because of these findings, the patient was preoperatively
diagnosed with pancreatic head cancer accompanied by
bile duct infiltration, and pylorus-preserving pancreati-
coduodenectomy was performed.
Surgical findings
At laparotomy, the abdomen was opened using an upper
abdominal midline incision. No ascites or peritoneal
seeding was noted. There were two palpable masses in
Figure 3 The resected specimen demonstrated tumors in both the bile duct and the pancreatic head. Stenosis due to bile duct invasion by
pancreatic head cancer was noted in both the pancreatic and the bile ducts (black arrow). Stenosis was also noted in the middle bile duct,
suggesting bile duct cancer (white arrow). The yellow arrows were the stump of the bile duct.
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head of the pancreas. The resected margins of the pan-
creatic and biliary ducts were subjected to rapid intraop-
erative pathological examination, and the bile duct
remnant was found to be positive for residual tumor
cells. After additional resection, rapid intraoperative
pathological examination confirmed clear margins. Pylorus-Figure 4 The pancreatic head tumor and the tumor at the confluence of t
tubular adenocarcinoma in the bile duct (a) (H.E., ×40), which was p53-pos
the pancreatic duct (c) (H.E., ×40), which was p53-negative (d).preserving pancreaticoduodenectomy and lymph node
dissection were performed.
Pathological findings
The resected specimen demonstrated tumors in both the
confluence of the cystic duct and the pancreatic head
(Figure 3). The tumor in the head of the pancreas was ahe cystic duct. Pathologic examination revealed a well-differentiated
itive (b), and a moderately differentiated tubular adenocarcinoma in
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N1, M0, stage II B) (UICC). The tumor at the conflu-
ence of the cystic duct was a well-differentiated tubular
adenocarcinoma (T2, N0, M0, stage II). Immunostaining
was conducted for the tumor markers mucin-1 (MUC1),
mucin-2 (MUC2), mucin-5AC (MUC5AC), mucin-6
(MUC6), cytokeratin-7 (CK7), cytokeratin-19 (CK19),
cytokeratin-20 (CK20), and tumor protein p53 (p53).
For both tumors, MUC1, MUC5AC, CK7, and CK19 were
positive, while MUC2 and CK20 were negative. However,
the pancreatic head tumor was negative for p53 and
MUC6, while these were both positive in the tumor at the
confluence of the cystic duct (Figure 4). Because two his-
tologically different tumors were observed in the head of
the pancreas, these were diagnosed as collision cancer in
which bile duct and pancreatic cancers collided (Figure 5).
The mapping of the resected specimen showed pancreatic
cancer and bile duct cancer colliding with the pancreatic
head (Figures 6 and 7).Figure 5 Two histologically different tumors observed in the head
of the pancreas. Within the pancreatic parenchyma, there is a ductal
structure with nuclear atypia (a) (H.E., ×40). Two types of carcinoma
collide with each other in the pancreas (b) (immunostaining for p53).Postoperative course
Gemcitabine chemotherapy was administered as adju-
vant chemotherapy following standard treatment guide-
lines for pancreatic cancer. However, the patient died of
multiple lung metastases 4 years and 1 month after
surgery.
Discussion
According to the criteria presented by Warren and
Gates [2], synchronous malignant neoplasms are defined
as follows: (1) each of the tumors must present a definite
picture of malignancy; (2) each must be distinct; and (3)
the possibility that one is a metastatic lesion caused by
the other must be ruled out. Also, Moertel et al. [3] arbi-
trarily classified tumors diagnosed within a 6-month
period as ‘simultaneous lesions’ and those diagnosed at
intervals of longer than 6 months as ‘interval lesions.’
The number of reports of dual cancers is increasing
every year due to the marked progress of diagnostic im-
aging technology in recent years, increasing frequency of
medical checkups, and the aging of the population [4-6].
The reported rate of pancreatic cancer associated with
other organ malignancies is 5.6% to 16.6% [7,8]. The
ranking of cancers presenting concomitantly with pan-
creatic cancer, from the highest to the lowest incidence,
is as follows: gastric cancer, thyroid cancer, lung cancer,
and breast cancer.
Collision cancers refer to tumors located in the same
organ or anatomical site. According to the World Health
Organization (WHO) histological classification, collision
tumors comprise at least two different malignant com-
ponents, with no mixed or transitional area in between.
Among intrapancreatic collision tumors, the incidence
of collision between an intraductal papillary mucinous
neoplasm and cancers of other types is high [9,10]. In
the pancreatic head area, adenocarcinoma and other
types of cancer have been reported; however, collision of
two adenocarcinomas is extremely rare. To the best of
our knowledge, this is the third reported case of a colli-
sion tumor between a bile duct adenocarcinoma and
pancreatic adenocarcinoma.
The symptoms and imaging-based findings of pancre-
atic head cancer accompanied by bile duct infiltration
are very similar to those of bile duct cancer accompan-
ied by pancreatic infiltration, and it is difficult to distin-
guish between these two conditions before surgery in
many cases. In our patient, a mass was palpated in the
pancreatic head during surgery, and a hard, hypertrophic
bile duct was also palpated at the confluence of the three
ducts slightly distal to the pancreatic mass. In the
resected specimen, a mass was also observed at the con-
fluence of the three ducts slightly proximal to the mass
in the pancreatic head, suggesting dual cancer. Obstruct-
ive jaundice associated with pancreatic head cancer is
Figure 6 The collision between the pancreatic cancer and the bile duct cancer at the resection site. The pancreatic cancer and the bile duct
cancer are colliding within the pancreatic head.
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the bile duct by the pancreatic cancer. However, in this
patient, the stenosis of the ducts within the head of the
pancreas and the hypertrophy of the bile duct at the
confluence of the three ducts were slightly separated
from each other. Thus, it is possible that this particular
dual cancer might have been diagnosed earlier if endo-
scopic ultrasonography or intraductal ultrasonography
had been performed.
The clinical behavior, associated prognosis, and malig-
nant potential of collision tumors are generally relatedFigure 7 Pancreatic cancer and bile duct cancer colliding with the
pancreatic head. The cholangiocarcinoma and the pancreatic head
cancer collided at the X mark.to the most aggressive of the colliding tumors [10]. Pan-
creatic carcinoma is associated with a very poor progno-
sis and a short survival period. Therefore, the prognosis
of patients with dual cancers involving pancreatic cancer
mainly depends on the prognosis associated with the
pancreatic cancer [11]. On the other hand, Geng Ming
Niu et al. [1] reported ten cases of collision cancer in
which the colliding cancers were pancreatic and periam-
pullary cancers, and the outcome was worse than that of
patients with pancreatic cancer alone.
In reports of collision cancers in which periampullary
carcinoids and adenocarcinomas collided, the difference
in the origins of the tumors was observed on CEA stain-
ing [12,13]. Hirono et al. [9] also reported differences
among the CK20, MUC2, and p53 expression levels on
immunostaining of cancers presenting in the bile duct
and the ampulla of Vater, showing that they were inde-
pendent cancers colliding with each other rather than
one type of cancer. In our patient, differences were
noted in the expression levels of p53 and MUC6, show-
ing that two histopathologically different cancers had
collided with each other in the pancreatic parenchyma.
No transition between the two cancers was noted, lead-
ing to a diagnosis of collision cancer composed of bile
duct and pancreatic cancers.
Conclusions
The pathological and immunohistochemical findings in
this case support the assertion that two separate cancers,
one originating from the bile duct and one from the
head of the pancreas, collided with each other, and thus,
this case can be defined as one of collision cancers. Our
case report is the third report of a case of collision can-
cer between a bile duct cancer and a pancreatic cancer.
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